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Summary
APOBEC family cytidine deaminases have been recently implicated as powerful mutators of 
cancer genomes. How APOBECs, which are ssDNA specific enzymes, gain access to 
chromosomal DNA is unclear. To ascertain the chromosomal ssDNA substrates of the APOBECs, 
we expressed APOBEC3A and APOBEC3B, the two most probable APOBECs mediating cancer 
mutagenesis, in a yeast model system. We demonstrate, using mutation reporters and whole 
genome sequencing, that APOBEC3A- and APOBEC3B-induced mutagenesis primarily results 
from the deamination of the lagging strand template during DNA replication. Moreover, our 
results indicate that both genetic deficiencies in replication fork-stabilizing proteins and chemical 
induction of replication stress greatly augment the mutagenesis of APOBEC3A and 3B. Taken 
together, these results strongly indicate that ssDNA formed during DNA lagging strand synthesis 
is a major substrate for APOBECs and may be the principal substrate in human cancers 
experiencing replication stress.
Introduction
Exposure to DNA damaging agents or deficiencies in DNA repair pathways commonly 
cause somatic mutations that underlie cellular transformation and carcinogenesis [reviewed 
in (Jackson and Bartek, 2009)]. We and others have recently identified the family of 
apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) cytidine 
deaminases as an endogenous source of DNA damage that mutagenizes many human 
cancers (Burns et al., 2013a, Nik-Zainal et al., 2012, Roberts et al., 2013, Burns et al., 
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2013b, Roberts et al., 2012). These enzymes normally function within lipoprotein 
metabolism (Teng et al., 1993) and the immune system to restrict viral and retrotransposable 
elements [reviewed in (Refsland and Harris, 2013)]. However, if unrestrained, APOBEC 
enzymes can also act as potent mutators of chromosomal DNA, where they deaminate 
cytidines preferentially within the trinucleotide sequences, TCA and TCT (referred to 
collectively as TCW; the mutated base is underlined) (Refsland and Harris, 2013). 
Consequently, APOBEC-mutagenized tumors contain an over-abundance of C to T and C to 
G substitutions within TCW sequences (Roberts et al., 2013, Alexandrov et al., 2013, Burns 
et al., 2013b). This mutation signature is widespread among many human cancer types, 
occurring prominently in bladder, cervical, head and neck, breast, lung, and esophageal 
cancers, and can account for up to 70% of the total mutation load within a tumor 
(Alexandrov et al., 2013, Roberts et al., 2013, Saraconi et al., 2014, Burns et al., 2013b).
While it is accepted that APOBEC cytidine deaminases likely cause the extensive 
mutagenesis of TCW sequences in cancer, the identity of the responsible APOBECs and 
their chromosomal substrates are still under debate. Both APOBEC3A (A3A) and 
APOBEC3B (A3B) have access to the nucleus (Bogerd et al., 2006), can mutagenize human 
genes (Burns et al., 2013a, Thielen et al., 2010, Caval et al., 2014), and have elevated 
mRNA levels in human cancers, with A3B expression correlating more strongly than A3A 
expression with the total mutation load across multiple cancer types (Burns et al., 2013b, 
Roberts et al., 2013). Additionally, A3B has been shown to be the major source of 
deaminase activity and mutagenesis in a panel of human breast cancer cell lines (Burns et 
al., 2013a). However, a human polymorphism that involves the deletion of A3B predisposes 
individuals to breast cancers (Kidd et al., 2007, Komatsu et al., 2008, Xuan et al., 2013). 
This deletion has been shown to stabilize the A3A mRNA (Caval et al., 2014), suggesting 
that increased A3A expression may cause the cancer predisposition. Additional analysis of 
the sequence specificities of A3A and A3B in a yeast model system indicate that these 
enzymes prefer different nucleotides at the −2 position, targeting YTCW and RTCW, 
respectively (where Y = C or T; R = G or A). Both of these motifs are over-represented in 
APOBEC-mutagenized tumors, with specific tumors having either an A3A- or A3B-like 
mutation signature (Chan et al., 2015). Based on these observations, A3A and A3B are 
currently prime candidates as cancer mutators. However, an association of APOBEC1 
expression with over-representation of TCW mutations in esophageal cancers (Saraconi et 
al., 2014) suggests that additional APOBECs may also be involved in mutagenesis in some 
cancers.
Biochemically, APOBEC family members prefer single stranded (ss) DNA as their substrate 
(Bransteitter et al., 2003, Suspene et al., 2004, Yu et al., 2004, Chen et al., 2006). Thus, 
double stranded chromosomal DNA should remain protected from these enzymes. However, 
normal cellular processes such as transcription, replication, and DNA repair frequently 
produce ssDNA intermediates that could serve as substrates for APOBEC-induced 
deamination, leading to the generation of mutations. Members of the human APOBEC 
family, including activation induced cytidine deaminase (AID) (Chaudhuri et al., 2003, Liu 
et al., 2008, Peters and Storb, 1996, Ramiro et al., 2003, Taylor et al., 2014) and 
APOBEC3G (A3G) (Taylor et al., 2014), as well as APOBEC homologs in lamprey (Lada et 
al., 2015), have all been shown to induce mutations with specificity to transcribed regions. 
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Moreover, many APOBECs have been shown to deaminate ssDNA processively, resulting 
in the formation of closely spaced ‘mutation clusters’ (Pham et al., 2007). The induction of 
mutation clusters in yeast through expression of these enzymes is dependent on activity of 
the uracil DNA glycosylase Ung1, indicating that in addition to transcription intermediates, 
DNA repair intermediates can also serve as substrates (Taylor et al., 2013). In human cells, 
an A3A-induced increase in γ-H2AX foci requires cells to be in S-phase (Landry et al., 
2011, Narvaiza et al., 2012), suggesting that this enzyme may deaminate ssDNA formed 
during DNA replication and ultimately induce DNA double strand breaks (DSBs) via 
subsequent enzymatic processing of the deoxyuridine by base excision repair. Nevertheless, 
the chromosomal substrates for A3A- and A3B-induced mutagenesis, remain undefined.
Here, we show that A3A and A3B mutagenize chromosomal DNA by deaminating the 
lagging strand template during DNA replication. Expression of either A3A or A3B in 
Saccharomyces cerevisiae caused strand-biased mutations in mutation reporters located to 
each side of a single, well-defined origin of replication. Similar strand-biased mutations 
were also present surrounding origins throughout the genome as evaluated by whole genome 
sequencing. A3A- and A3B-induced mutations 5′ of origins were primarily G to A 
substitutions, while 3′ of origins C to T substitutions predominated. This pattern of 
mutagenesis is consistent with deamination of ssDNA on the lagging strand template. 
Genetic deficiencies in proteins involved in replication fork stability (i.e. Rfa1 or Tof1) 
greatly augmented the mutagenicity of A3A and A3B, as did chemical inhibition of 
replication by hydroxyurea (HU). Thus, A3A and A3B enzymes may capitalize on the 
constant proliferation and/or replication stress occurring in cancers to mediate their 
mutagenic effects.
Results
To determine the targets of A3A- and A3B-induced mutagenesis, we generated codon-
optimized constructs and expressed these enzymes within strains of the yeast S. cerevisiae, 
which contained an array of forward mutation reporters (ADE2, URA3, and CAN1) inserted 
into the LYS2 gene on chromosome II. The A3A and A3B expression constructs produced 
similar amounts of their respective APOBEC mRNA (Figure S1) and were mutagenic, 
increasing the CAN1 mutation frequency approximately 2- to 189-fold compared to a vector 
only control (Figure 1A). As expected, deletion of the uracil-DNA glycosylase, Ung1, in 
A3A- and A3B-expressing strains further increased the CAN1 mutation frequency 7- to 29-
fold, confirming that A3A and A3B expression was inducing mutations by deamination of 
cytidine to uridine within chromosomal DNA. We subsequently sequenced canavanine-
resistant (CanR) clonal isolates from ung1Δ strains (to assess all APOBEC-induced 
deamination events) to identify the mutations that inactivated CAN1. Both A3A and A3B 
induced strand-biased mutations within their favored sequence motif (Figure 1B) (i.e. TCW 
or WGA on the opposite DNA strand). If A3A and A3B target transcriptional intermediates 
in CAN1, as has been shown for AID and A3G, the direction of CAN1 transcription would 
render the top DNA strand single stranded and A3A and A3B would produce C to T 
substitutions (Figure 1C). Surprisingly, both A3A and A3B produced predominantly G to A 
substitutions (Figure 1D and Table S1). This result indicates that these enzymes 
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deaminated only the bottom DNA strand in the CAN1 gene. Thus, A3A and A3B appear to 
target a source of ssDNA other than transcription in this region of the yeast genome.
The DNA template present during lagging strand synthesis is an additional source of ssDNA 
(reviewed in (Balakrishnan and Bambara, 2011)) that may serve as an alternative substrate 
for A3A and A3B within CAN1. Within this yeast strain, CAN1 is asymmetrically positioned 
between two neighboring origins of replication, being located 16 kB 5′ of a well-defined 
origin of replication, ARS216 and 57 kB 3′ of ARS215. Therefore, most replication forks 
traveling through CAN1 will originate from ARS216 and produce templating ssDNA during 
lagging strand synthesis on the bottom DNA stand. Consequently, deamination of this strand 
would result in G to A substitutions, which is consistent with our observed mutation 
spectrum. To test if A3A and A3B preferentially deaminate ssDNA formed in the lagging 
strand template, we expressed these enzymes in an isogenic yeast strain previously 
engineered to investigate the ability of the DNA alkylating agent, methyl methanesulfonate, 
to induce replication-associated mutation clusters (Roberts et al., 2012). The array of 
forward mutation reporters in this strain is positioned in an intergenic region 7 kB 3′ of 
ARS216 and 134 kB 5′ of the neighboring downstream origin, ARS220. Consequently, 
replication proceeds through CAN1 in this location in the opposite direction, causing lagging 
strand-associated ssDNA to be formed on the top DNA strand (Figure 1C). Thus, mutations 
in CAN1 stemming from DNA damage accumulating in replication-associated ssDNA are 
expected to be complementary base substitutions in each strain. Expression of A3A and 
A3B caused similar CanR frequencies with the CAN1 gene positioned 3′ of ARS216 (Figure 
1A) as was observed with the reporter 5′ of the origin. However, sequencing of CanR 
mutants in the 3′ location produced a spectrum consisting predominantly of C to T 
substitutions (Figure 1D and Table S1), which is consistent with replication-associated 
ssDNA being the primary target of A3A and A3B within this locus. Similar strand-bias 
mutations consistent with the deamination of ssDNA in the lagging strand template also 
occurred in UNG proficient cells (Figure 1D and Table S1). This indicates that even with 
active repair of APOBEC-induced deoxyuridine, the formation of these lesions in 
replication-associated ssDNA is the major source of mutations in this system.
To ensure our results using the CAN1 reporter system were universal and not affected by 
specifics of the location of the reporter, we next assessed whether A3A and A3B 
mutagenized the lagging strand template elsewhere in the yeast genome. To do this, we 
constructed homozygous diploid ung1Δ yeast strains containing A3A and A3B expression 
cassettes integrated into the LEU2 gene on chromosome III. These stains enable 
maintenance of the expression constructs without selection, as well as accumulation of a 
significant number of APOBEC-induced mutations whose distribution is less likely to be 
altered by purifying selection (Lujan et al., 2014). We subsequently propagated outgrowth 
lines of these yeast for three months (~900 generations) and sequenced the genomes of 
independent clonal isolates to determine the location and identity of the APOBEC-induced 
mutations (Figure 2A and Table S2). Through this prolonged growth, A3A and A3B 
induced an estimated 0.09 and 0.16 mutations per genome per generation, respectively 
(Table S2). A3B-induced C to T and G to A mutations occurred in nearly equal abundance 
within genes transcribed on the top strand as well as in genes transcribed on the bottom 
Hoopes et al. Page 4
Cell Rep. Author manuscript; available in PMC 2016 March 09.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
strand (Figure 2B), indicating that deamination of the single stranded non-transcribed strand 
occurs infrequently. A3A expression induced a statistically significant (p<0.02 by two-tailed 
chi-square test), but slightly favors C to T mutations on the non-transcribed strand, 
indicating that this enzyme is capable of deaminating transcriptional intermediates at a low 
level. When we grouped mutations according to their relative distance between neighboring 
origins, both A3A and A3B predominantly induced C to T substitutions 3′ of origins and G 
to A substitutions to the 5′ side of origins (Figure 2C). This pattern occurred despite an 
equal representation of the APOBEC target motif between DNA strands across the genome 
(Figure 2C), and indicates that the lagging strand template, not the non-transcribed strand of 
genes, is the primary substrate for A3A and A3B in this system.
During cancer development, dysfunctional replication forks are common due to hyper-
initiation of replication, which results in replication stress [reviewed in (Macheret and 
Halazonetis, 2015, Hills and Diffley, 2014)]. We therefore evaluated whether the loss of 
replication fork integrity provided additional opportunity for A3A and A3B to deaminate 
chromosomal DNA. We first assessed APOBEC-induced mutagenesis within yeast 
containing a hypomorphic RFA1 allele (t33; S373P). RFA1 encodes the large subunit of the 
ssDNA binding protein, Replication Protein A (RPA), which binds and protects the lagging 
strand template during DNA replication. Rfa1-t33 has been shown to have reduced ssDNA 
binding capacity compared to the wild type protein due to a point mutation in the DNA 
binding domain (Deng et al., 2014). Expression of either A3A or A3B in rfa1-t33 ung1Δ 
strains resulted in 2- to 6-fold higher CanR frequencies compared to ung1Δ strains (Figure 
3A). The CAN1 mutation spectra on either side of ARS216 in rfa1-t33 ung1Δ strains 
retained an enrichment of substitutions at TCW sequences as well as strand-biased G to A 
changes 5′ and C to T changes 3′ of the origin (Figure 3B and Table S1). These results 
indicate that the increase in A3A- and A3B-induced mutagenesis in rfa1-t33 ung1Δ strains is 
the result of A3A and A3B acting on a more exposed lagging strand template. Thus, 
although A3A and A3B can access the lagging strand template, components of the 
replication fork complex provide some protection against these enzymes during normal 
replication. Surprisingly, we observed within rfa1-t33 ung1Δ strains a significant increase in 
the number of CanR mutants containing multiple APOBEC-induced mutations (p=0.01 by 
Fisher's Exact Test) (Table 1 and Table S1). Some CanR isolates contained up to 6 strand-
coordinated mutations which were likely induced in a single event, suggesting that loss of 
full RPA functionality may facilitate the processivity of APOBEC enzymes (Lada et al., 
2011, Pham et al., 2007). We tested an additional null strain to determine whether the 
increased APOBEC-induced mutagenesis observed in the rfa1-t33 strains is generalizable to 
any deficiency in replication fork stability. Tof1 functions with Csm3 at the replication fork 
to prevent uncoupling of the replicative polymerases from the MCM helicase, and deletions 
of these factors have been shown to result in the accumulation of replication-associated 
ssDNA in response to HU treatment (Katou et al., 2003). As in rfa1-t33 strains, A3A and 
A3B both induced 4- to 14-fold more CanR mutants in tof1Δ ung1Δ strains than in ung1Δ 
strains (Figure 3A) confirming that general loss of replication fork integrity increases the 
susceptibility of forks to APOBEC-induced deamination. Interestingly, sequencing of CAN1 
in the tof1Δ ung1Δ strain revealed strand-biased mutations 3′ of ARS216, while C to T and 
G to A mutations occurred equally 5′ of the origin (Figure 3B and Table S1). This result 
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suggests that A3A and A3B either gain access to ssDNA formed on both the leading and 
lagging strands in the absence of Tof1 (Katou et al., 2003) or that altered origin firing and 
replication fork progression in the tof1 null strains (Tourriere et al., 2005, Hayano et al., 
2011) enables more forks originating from ARS215 to replicate the 5′ positioned CAN1 
gene.
In addition to genetic replication fork defects, replication stress can be induced by exposure 
to drugs like HU (Zeman and Cimprich, 2014). HU inhibits the activity of ribonucleotide 
reductase, resulting in decreased deoxyribonucleotide pools and slowed DNA synthesis 
(Bianchi et al., 1986, Slater, 1973). We therefore decided to test whether replication stress 
with a fully competent replisome could augment APOBEC mutagenesis. We treated ung1Δ 
yeast strains containing either a vector control plasmid or A3A and A3B expression 
plasmids with HU for three days. Over this period, HU treated yeast displayed a dose-
dependent decrease in cell growth indicating a slowing of replication and induction of 
replication stress (Figure 4A). In ung1Δ strains containing either A3A or A3B, HU 
treatment dramatically increased mutagenesis up to 8-fold over non-treated controls and 10- 
to 186-fold over corresponding vector transformed ung1Δ strains (Figure 4B). The mutation 
spectra in HU-treated strains maintained a strand-biased signature consistent with A3A and 
A3B mutagenizing the lagging strand template 3′ of ARS216. As seen in the tof1Δ ung1Δ 
strains, however, the mutational strand-bias 5′ of the origin was lost (Figure 4C and Table 
S1). This loss of strand-bias could result from HU treatment inducing ssDNA on both the 
leading and lagging strands through the functional uncoupling of the MCM helicase and 
replicative polymerases. However, for the HU treatment to differentially alter the mutation 
spectra in the two CAN1 locations, ssDNA would have to be formed in the lagging strand in 
a region specific manner. Alternatively, the loss of strand bias 5′ of ARS216 could be due to 
HU disrupting the timing of origin firing and the kinetics of replication (Poli et al., 2012), 
which could allow more forks originating from ARS215 to replicate CAN1. The synergistic 
elevation of CAN1 mutation frequency in HU treated yeast expressing A3A or A3B thus 
likely resulted from HU treatment increasing the amount of ssDNA substrate available to 
these enzymes. As in rfa1-t33 ung1Δ strains, several CanR isolates contained multiple 
strand-coordinated mutations within CAN1 (Table 1 and Table S1), reminiscent of 
previously reported DNA damage-induced mutation clusters and the APOBEC-induced 
kataegis events observed in human tumors (Nik-Zainal et al., 2012, Roberts et al., 2012). 
Therefore, chemically-induced replication stress greatly augments APOBEC mutagenesis, 
suggesting that other forms of replication stress that occur during carcinogenesis may 
likewise facilitate the extensive editing of tumor genomes by these enzymes.
Discussion
Using both mutation reporter systems and whole genome sequencing, we have shown that 
A3A and A3B, the two most likely enzymes involved in the APOBEC-induced mutagenesis 
observed in cancer, strongly mutagenize the lagging strand template during DNA 
replication. In addition, mutations identified by whole genome sequencing lacked a strong 
transcriptional strand-bias. This observation indicates that A3A- and A3B-induced 
deamination of transcriptional intermediates is limited within this system and that ssDNA 
formed during lagging strand synthesis is the primary substrate for these enzymes. Other 
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APOBEC enzymes have been shown to be capable of deaminating ssDNA formed during 
transcription. AID-induced deamination of immunoglobulin genes is dependent on 
transcription of the immunoglobulin locus (Peters and Storb, 1996) and AID-induced 
mutation frequencies can be greatly elevated by increasing the transcription level of 
mutation reporters in E. coli (Ramiro et al., 2003). In biochemical assays, AID, A3G, and 
A3A deamination can be made dependent on transcription of the target DNA (Pham et al., 
2003, Pham et al., 2007, Pham et al., 2013, Love et al., 2012). Moreover, expression of AID 
or A3G in yeast yields an enrichment of mutations at active RNA polymerase pre-initiation 
sites (Taylor et al., 2014). These effects may be facilitated by extremely high levels of 
transcription, pausing of RNA polymerase, and formation of R-loops and secondary 
structures that would increase the size and time a transcribed region is single stranded. As 
such instances are likely limited to specific subsets of genes, the contribution of 
transcription-associated ssDNA to the overall distribution of APOBEC-induced mutations 
may be small. Supporting this, our global analysis of A3A- and A3B-induced mutations 
detected a small, but significant transcriptional strand-bias for A3A-induced mutations. 
Moreover, recent whole genome analyses of A3G-induced mutations in E. coli likewise 
observed a predominance of mutations originating from the deamination of cytidine in the 
lagging strand template over the non-transcribed strands of genes, regardless of uracil DNA 
glycosylase status (Bhagwat et al., 2016).
The mechanistic basis for how A3A and A3B choose their substrates is currently unclear. 
AID's specificity for transcription-associated ssDNA appears to be facilitated by interactions 
with multiple proteins present in the transcription apparatus (Chaudhuri et al., 2004, Pavri et 
al., 2010, Willmann et al., 2012) as well as long non-coding RNAs transcribed from the 
immunoglobulin switch regions (Zheng et al., 2015). In the absence of direct recruitment to 
a specific ssDNA substrate, the activity of the majority of APOBECs may be dictated by the 
abundance and persistence of the ssDNA intermediate. As transcription bubbles are 
relatively small (~10-20 nucleotides) (Pal et al., 2005, Choder and Aloni, 1988), APOBEC 
mutagenesis of transcription intermediates would appear to be limited. In comparison, both 
lagging strand synthesis and the homology-directed repair (HR) of DSBs produce 
significantly larger stretches of ssDNA (approximately 200 nucleotides [(Smith and 
Whitehouse, 2012) and references within] and 1-2 kilobases (Zhou et al., 2014, Chung et al., 
2010), respectively) that A3A and A3B can mutagenize. Although HR resection tracks may 
produce more ssDNA per single DSB than the synthesis of one Okazaki fragment, the 
number of DSBs in a cell is likely very small compared to the number of Okazaki fragments 
formed during each round of DNA replication. Thus, the lagging strand template the favored 
substrate of multiple APOBEC enzymes based solely on the amount of ssDNA generated.
The susceptibility of ssDNA replication intermediates to A3A and A3B may be one of the 
key factors enabling the extensive APOBEC mutagenesis observed in many cancer types. 
The mutation spectra of other cancer mutagens, like UV light and tobacco smoke, display 
transcription-associated strand-biases presumably due to the favored repair of the 
transcribed stand by transcription-coupled nucleotide excision repair (Alexandrov et al., 
2013). However, a small transcription related strand-bias among APOBEC mutations has 
only been observed specifically in highly expressed genes in two bladder cancer patients 
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(Nordentoft et al., 2014). Recent analyses of the distribution of APOBEC signature 
mutations in breast and lung cancers have revealed that these mutations are enriched in 
gene-rich, early replicating regions of the genome (Kazanov et al., 2015). However, within 
these regions, APOBEC-induced mutations occurred equally in transcribed and non-
transcribed DNA as well as on the transcribed and non-transcribed strands. More extensive 
computational analysis of 590 whole genome sequenced tumors from 14 tumor types 
revealed that overall APOBEC signature cancer mutations display strand-bias, but that these 
biases are more consistent with the enzymes deaminating cytidines within ssDNA on the 
lagging strand template than deamination of the non-transcribed strand during transcription 
(Haradhvala et al., 2016). This suggests that as in yeast and E. coli, replication and not 
transcription is the predominant APOBEC substrate within human tumors.
APOBEC-induced mutations could thus accumulate simply because of the large number of 
cell divisions and accompanying DNA replication that highly proliferative cancer cells 
undergo (Shibata and Lieber, 2010). Replication stress conditions that occur frequently in 
tumors likely further exacerbate this effect. Activation of oncogenes like Cyclin E or H-Ras 
during cancer development dysregulate the coordination of replication origin firing 
[reviewed in (Macheret and Halazonetis, 2015, Hills and Diffley, 2014)]. Consequently, 
many tumor cells over-replicate their genomes, which can result in the exhaustion of factors 
that maintain fork stability, and formation of even higher amounts of ssDNA (Toledo et al., 
2013). Our results indicate that genetic disruption of replication fork integrity or chemical 
induction of replication stress facilitates A3A and A3B mutagenesis, indicating that 
oncogene-induced replication stress may do so as well. Supporting this, human tumors likely 
experiencing replication stress due to the mutation or silencing of the tumor-suppressor, 
FHIT, have reportedly higher numbers of APOBEC signature mutations in lung 
adenocarcinoma (Waters et al., 2015). Additionally, overexpression of the breast cancer-
associated oncogene human epidermal growth factor-2 (Her2) in mice elevates DNA 
damage response signaling in tumors, which is an indicator of increased replication stress 
(Reddy et al., 2010). This observation coupled with our results indicating that replication 
stress increases A3A- and A3B-induced mutagenesis offer a possible explanation for the fact 
that breast cancers experiencing the overexpression of Her2 have been shown to have more 
APOBEC-signature mutations than other breast cancer subtypes (Roberts et al., 2013). Thus, 
the dysregulation of APOBEC expression and significant availability of their ideal substrate 
due to hyper-replication may produce a “perfect storm” enabling extreme mutagenesis in 
human cancer.
Experimental Procedures
Construction of Expression Plasmids
The expression plasmids used in this study were constructed from the centromeric yeast 
expression plasmid, pCM252 (Belli et al., 1998). The TRP1 selectable marker of pCM252 
was exchanged for hygromycin resistance by co-transforming yeast with the plasmid and a 
HygroMX cassette, PCR amplified with the forward and reverse primers, 5′-
AGGGCATTGGTGACTATTGAGCACGTGAGTATACGTGATTAAGCACACAAAGGC
AGCTTGG AGTCGTACGCTGCAGGTCGAC and 5′-
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TAATCTAAGCGCATCACCAACATTTTCTGGCGTCAGTCCACCAGCTAACATAAA
ATGTAAGC TTCGATGAATTCGAGCTCG. Hygromycin-resistant, tryptophan-
auxotrophic transformants where selected to identify isolates containing recombined plasmid 
(named pySR419) where the HygroMX cartridge had replaced TRP1 through homologous 
recombination. Pure plasmid was subsequently isolated and proper integration of HygroMX 
verified by restriction digest. A3A and A3B cDNAs were codon-optimized for expression in 
yeast and synthesized as gene blocks with appended 5′StuI and 3′ClaI restriction sites 
(DNA2.0, Menlo Park, CA). These gene blocks were digested, cloned into the StuI and ClaI 
sites of pySR419, and the resulting plasmids were sequenced to verify the integrity of A3A 
and A3B.
Yeast Strains and Culture
All yeast strain utilized in this study were constructed in the CG379 genetic background, a 
derivative of S288C (Morrison et al., 1991). Detailed descriptions of strain constructions can 
be found the supplemental experimental procedures. The genotypes of each strain used is 
listed in Table S3. Yeast were grown using standard techniques described in (Sherman et 
al., 1986) on standard rich media (YPDA) or synthetic complete (SC) media.
Determination of Mutation Frequencies
For all experiments measuring APOBEC-induced mutations, A3A and A3B were expressed 
at basal levels (i.e. without induction) from a tetracycline inducible promoter. To determine 
CanR frequencies for clonal strains transformed with either an empty vector control, A3A 
expression plasmid, or A3B expression plasmid, ~200 yeast cells were plated on YPDA 
media supplemented either with hygromycin (to select for maintenance of the plasmid) or 
hygromycin and HU and grown at 30°C for three days. Afterward, independent colonies 
were re-suspended in water and plated on synthetic complete media or SC-arginine 
supplemented with 0.006% canavanine (to select for CAN1 mutants) at appropriate dilutions 
to yield clearly independent colonies. Colonies were allowed to grow on selective and 
complete media for three days at 30°C and subsequently imaged and counted using Quantity 
One software (Bio-Rad, Hercules, CA). The frequency of CanR mutants was calculated 
using the4 following formula:
The medians of each the independent replicates were compared pairwise between different 
experimental conditions using the Mann-Whitney Rank Test.
CAN1 Mutation Spectra
Following three days growth at 30°C on YPDA media containing either hygromycin or 
hygromycin and HU, independent colonies of ung1Δ strains transformed with either A3A or 
A3B expression constructs were replica plated to SC-arginine media supplemented with 
0.006% canavanine and allowed to grow at 30°C for an additional three days. A single CanR 
papillae was selected per independent colony and was additionally clonally isolated by 
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single cell streaking. Genomic DNA was isolated from these clones and the CAN1 gene was 
PCR amplified (primers listed in Table S4). CAN1 PCR products were Sanger sequenced 
(Eton Biosciences, San Diego, CA and GenScript, Piscataway, NJ) and mutations 
inactivating CAN1 (Table S1) identified using the Geneious software package (Biomatters 
Limited). The preferred trinucleotide sequences mutated in CAN1 following A3A or A3B 
expression were generated using webLogo (http://weblogo.berkeley.edu/logo.cgi) (Crooks et 
al., 2004).
Whole Genome Sequencing and Mutation Calling
The accumulation of APOBEC-induced mutations was conducted similar to (Lujan et al., 
2014). Briefly, ~200 diploid yeast cells deficient in ung1 and containing A3A or A3B 
integrated into the LEU2 locus of chromosome III were plated on rich media and grown at 
30°C for three days. 10-20 independent colonies for each yeast strain were selected and 
passaged through bottlenecks for three months (~900 generations) on rich media at 30°C to 
establish outgrowth lines. After the three month growth period, a single clonal isolate from 
each line was obtained. Total genomic DNA was isolated from these clones as well as from 
a sample of the bulk yeast prior to passaging (time zero). These genomic DNAs were 
subjected to high throughput paired-end sequencing similar to (Roberts et al., 2012) on an 
Illumina HiSeq2500 (San Diego, CA). Raw sequencing reads can be accessed from the 
NCBI short read archive database under accession number SRP067952. Paired-end reads 
were mapped with CLC genomics Workbench 7.5 (Qiagen) using default settings at greater 
than 50x coverage to a reference of ySR128 based on the publically available S288C 
reference (obtained from the Saccharomyces Genome Database, http://
www.yeastgenome.org) and constructed as in (Roberts et al., 2012). Reads mapping to 
multiple locations in the genome were discarded. Mutations were called similarly to 
(Sakofsky et al., 2014). Briefly, homozygous and heterozygous mutations were identified as 
base differences relative to the reference sequence that occurred in greater than 45% of 
reads. All mutations were covered by at least 9 reads. Due to being likely mapping artifacts, 
mutations occurring in regions annotated as “Repeat Regions” and “LTR” in the S288C S. 
cerevisiae reference were removed from analysis as were mutations that occur at positions 
where mapping of reads from a non-mutagenized reference strain resulted in greater than 
20% of reads containing non-reference sequence. Mutations that occurred in strains prior to 
outgrowth (identified as mutations occurring in the time zero sample) were also removed.
Analyses of Whole Genome Mutation Distribution
The position of genes and origins of replication were obtained from the annotations in the 
S288C reference UCSC sacCer2 (downloaded from NCBI on June 16, 2008) and converted 
into the coordinates of the ySR128 reference. APOBEC-induced mutations were placed into 
groups based upon whether they occurred in genes transcribed on the top or bottom DNA 
strand, and their location in relationship to the percent distance between neighboring origins. 
The number of C to T substitutions was compared to the number of G to A substitutions and 
the frequency of the favored APOBEC target sequence.
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Statistical analyses
All statistical analysis were conducted as described in the text using the Graphpad Prism 
software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. APOBEC3A and 3B induce strand-bias mutations around ARS216
(A) Frequencies of canavanine-resistance (CanR) induced in WT and ung1Δ yeast following 
transformation with vector control plasmid, A3A expression plasmid, or A3B expression 
plasmid. CanR frequency was determined in isogenic strains with the CAN1 gene located 
either 16 kB 5′ of the origin of replication, ARS216, or 7 kB 3′ of ARS216. Horizontal bars 
and numeric values indicate the median frequency of six or seven independent replicates. 
Statistical significance was determined by two-tailed non-parametric Mann-Whitney Rank 
test. See also Figure S1. (B) Sequence logo describing the favored trinucleotide sequences 
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mutated by A3A (top) and A3B (bottom) in ung1Δ yeast. See also Table S1. (C) Specific 
deamination of ssDNA formed in a transcription bubble would result in C to T transitions 
(red ball) within CAN1 regardless of whether the gene is positioned 5′ or 3′ of ARS216. In 
contrast, deamination of ssDNA formed during lagging strand synthesis would result in G to 
A substitutions (green ball) 5′ and C to T substitutions 3′ or the origin. (D) The number of G 
to A (green) and C to T (red) substitutions induced in the CAN1 gene (located 5′ and 3′ of 
ARS216) by A3A and A3B in ung1Δ and UNG1 yeast as determined by sequencing 
independent CanR isolates. P-values were determined using a one-tailed g-test goodness-of-
fit comparing the ratio of C to T substitutions to G to A substitutions to an expected 1:1 
ratio. See also Table S1.
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Figure 2. Genome-wide strand-bias of A3A and A3B mutations between neighboring origins of 
replication
(A) Distribution of C to T (red) and G to A (green) mutations induced by A3A (top) and 
A3B (bottom). Yeast chromosomes are displayed in gray. (B) The relative abundance of 
A3A- and A3B-induced C to T mutations (red) and G to A mutations (green) in yeast genes 
+/− 500 nucleotides transcribed on the bottom strand (B) or the top strand (T). P-values were 
determined using a two-tailed chi-square test comparing the numbers of each mutation type 
to the number of A3A- and A3B-targeted TC (red) or GA (green) dinucleotides occurring in 
these regions. (C) The relative abundance of A3A- and A3B-induced C to T mutations (red) 
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and G to A mutations (green) according to the fractional distance between neighboring 
replication origins. Lines represent linear trend lines fitting the fractional abundance of C to 
T (red) and G to A (green) mutations across the entire fractional distance between 
neighboring origins. A statistical significance of p<0.0001 was determined by comparing the 
number of each mutation type in each decile bin to the corresponding abundance of TC or 
GA dinucleotides, by chi-square test. See also Table S2.
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Figure 3. Deletion of replication fork stability factors exacerbates A3A- and A3B-induced 
mutagenesis around ARS216
(A) Frequencies of CanR induced in wild type, rfa1-t33, tof1Δ, ung1Δ, rfa1-t33 ung1Δ, and 
tof1Δ ung1Δ yeast following transformation with vector control plasmid, A3A expression 
plasmid, or A3B expression plasmid. Horizontal bars and numeric values indicate the 
median frequency of six or seven independent replicates. P-values were determined by two-
tailed non-parametric Mann-Whitney Rank test. (B) The number of G to A (green) and C to 
T (red) substitutions induced in the CAN1 gene (located 5′ and 3′ of ARS216) by A3A and 
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A3B in ung1Δ yeast in the genetic backgrounds mentioned in (A) as determined by 
sequencing independent CanR isolates. P-values were determined using a two-tailed Fisher's 
Exact test comparing the ratio of C to T substitutions to G to A substitutions between 
indicated genotypes. See also Table S1.
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Figure 4. Chemically-induced replication stress augments A3A- and A3B-induced mutagenesis
(A) HU treatment causes a dose-dependent decrease in cell growth in ung1Δ yeast. Shown 
are medians and ranges for 18 independent replicates at each HU dose. P-values were 
determined by two-tailed non-parametric Mann-Whitney Rank test comparing untreated 
yeast to yeast treated with 50 mM HU. (B) Frequencies of CanR induced in ung1Δ yeast 
treated with 0, 12.5, 25, or 50 mM HU following transformation with vector control 
plasmid, A3A expression plasmid, or A3B expression plasmid. Horizontal bars and numeric 
values indicate the median frequency of six or seven independent replicates. P-values were 
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determined by two-tailed non-parametric Mann-Whitney Rank test. (C) The number of G to 
A (green) and C to T (red) substitutions induced in the CAN1 gene by A3A and A3B in 
untreated or 50mM HU treated ung1Δ yeast as determined by sequencing independent CanR 
isolates. P-values were determined using a two-tailed Fisher's Exact test comparing the ratio 
of C to T substitutions to G to A substitutions between indicated treatments. See also Table 
S1.
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Table 1
Summary of CAN1 sequencing results in strains expressing A3A and A3B
Source of replication stress combined with A3A or A3B expression in ung1Δ strains
None 50mM HU rfa1-t33 tof1Δ 
Total CanR mutants sequenced 190 122 108 120
CanR mutants with APOBEC signature mutation(s) 188 116 106 120
Frequency of multiple strand-coordinated 
APOBEC-signature mutations
0.011 0.025 0.056 0.008
Number of mutations present in each CanR mutant 
with multiple strand-coordinated APOBEC-
signature mutations
2, 2 2, 2, 6 2, 2, 2, 2, 2, 5, 6 2
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